Concepts (265)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 29 | 2021 | 2223 | 2.040 |
Why?
|
| Brain Neoplasms | 11 | 2021 | 371 | 1.810 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2018 | 2324 | 1.310 |
Why?
|
| Alzheimer Disease | 5 | 2022 | 565 | 1.220 |
Why?
|
| Brain | 18 | 2022 | 2176 | 1.130 |
Why?
|
| Diffusion Tensor Imaging | 12 | 2022 | 211 | 1.080 |
Why?
|
| Contrast Media | 6 | 2021 | 595 | 1.050 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 7 | 2022 | 239 | 0.960 |
Why?
|
| Cognitive Dysfunction | 3 | 2016 | 176 | 0.940 |
Why?
|
| Spinal Cord | 3 | 2010 | 244 | 0.920 |
Why?
|
| Antineoplastic Agents, Immunological | 3 | 2021 | 66 | 0.900 |
Why?
|
| Apolipoproteins E | 2 | 2016 | 92 | 0.900 |
Why?
|
| Pyramidal Tracts | 3 | 2017 | 45 | 0.790 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2018 | 373 | 0.780 |
Why?
|
| Head | 2 | 2018 | 59 | 0.750 |
Why?
|
| Radiation Dosage | 5 | 2018 | 419 | 0.750 |
Why?
|
| Glioma | 2 | 2020 | 140 | 0.740 |
Why?
|
| Electrodes, Implanted | 1 | 2021 | 98 | 0.740 |
Why?
|
| Neuroimaging | 3 | 2021 | 122 | 0.730 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2021 | 44 | 0.720 |
Why?
|
| Organometallic Compounds | 4 | 2021 | 95 | 0.720 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2020 | 18 | 0.710 |
Why?
|
| Rituximab | 1 | 2020 | 61 | 0.700 |
Why?
|
| Neck | 3 | 2015 | 62 | 0.700 |
Why?
|
| Gadolinium DTPA | 3 | 2021 | 48 | 0.660 |
Why?
|
| Electroencephalography | 1 | 2021 | 418 | 0.630 |
Why?
|
| Radiation Monitoring | 1 | 2018 | 41 | 0.620 |
Why?
|
| Thyroid Gland | 3 | 2015 | 67 | 0.620 |
Why?
|
| Female | 43 | 2021 | 38074 | 0.610 |
Why?
|
| Foramen Magnum | 1 | 2017 | 3 | 0.600 |
Why?
|
| Occipital Bone | 1 | 2017 | 11 | 0.590 |
Why?
|
| Humans | 61 | 2022 | 68618 | 0.590 |
Why?
|
| Aged | 21 | 2022 | 14862 | 0.580 |
Why?
|
| Thyroid Neoplasms | 2 | 2015 | 68 | 0.580 |
Why?
|
| Iodine | 1 | 2017 | 42 | 0.580 |
Why?
|
| Blood Volume | 4 | 2013 | 47 | 0.560 |
Why?
|
| Movement Disorders | 1 | 2017 | 58 | 0.560 |
Why?
|
| Entorhinal Cortex | 1 | 2016 | 11 | 0.560 |
Why?
|
| Preoperative Care | 1 | 2018 | 275 | 0.550 |
Why?
|
| Radiographic Image Enhancement | 1 | 2017 | 208 | 0.530 |
Why?
|
| Male | 39 | 2021 | 37321 | 0.530 |
Why?
|
| White Matter | 4 | 2022 | 174 | 0.520 |
Why?
|
| Anomia | 1 | 2015 | 9 | 0.520 |
Why?
|
| Multiple Sclerosis | 1 | 2017 | 132 | 0.520 |
Why?
|
| Multidetector Computed Tomography | 1 | 2015 | 60 | 0.480 |
Why?
|
| Oligodendroglioma | 3 | 2013 | 18 | 0.480 |
Why?
|
| Adult | 27 | 2021 | 21403 | 0.470 |
Why?
|
| Child, Preschool | 9 | 2021 | 3187 | 0.470 |
Why?
|
| Middle Aged | 24 | 2022 | 21147 | 0.460 |
Why?
|
| Anisotropy | 6 | 2017 | 105 | 0.460 |
Why?
|
| Atrophy | 5 | 2016 | 112 | 0.450 |
Why?
|
| Retrospective Studies | 14 | 2021 | 7277 | 0.430 |
Why?
|
| Meglumine | 3 | 2021 | 16 | 0.430 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2013 | 181 | 0.420 |
Why?
|
| Stroke | 6 | 2018 | 2163 | 0.410 |
Why?
|
| Organs at Risk | 1 | 2011 | 9 | 0.390 |
Why?
|
| Algorithms | 3 | 2018 | 1196 | 0.380 |
Why?
|
| Brain Ischemia | 1 | 2017 | 665 | 0.380 |
Why?
|
| Blood Flow Velocity | 2 | 2009 | 172 | 0.380 |
Why?
|
| Phantoms, Imaging | 4 | 2016 | 189 | 0.350 |
Why?
|
| Image Interpretation, Computer-Assisted | 5 | 2015 | 237 | 0.350 |
Why?
|
| Arteriovenous Malformations | 1 | 2010 | 34 | 0.350 |
Why?
|
| Child | 7 | 2021 | 6405 | 0.330 |
Why?
|
| Neural Pathways | 6 | 2017 | 324 | 0.320 |
Why?
|
| Epilepsy, Temporal Lobe | 3 | 2016 | 138 | 0.320 |
Why?
|
| Cerebellar Diseases | 1 | 2008 | 6 | 0.320 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2008 | 24 | 0.310 |
Why?
|
| Space Flight | 2 | 2020 | 40 | 0.310 |
Why?
|
| Cranial Sinuses | 1 | 2008 | 11 | 0.310 |
Why?
|
| Infant | 6 | 2021 | 2891 | 0.310 |
Why?
|
| Adolescent | 10 | 2021 | 8912 | 0.310 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2008 | 20 | 0.300 |
Why?
|
| Trigeminal Nerve Diseases | 1 | 2007 | 7 | 0.300 |
Why?
|
| Brain Mapping | 3 | 2012 | 532 | 0.300 |
Why?
|
| Aged, 80 and over | 9 | 2022 | 4848 | 0.300 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2007 | 13 | 0.300 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2021 | 446 | 0.300 |
Why?
|
| Fetal Diseases | 1 | 2008 | 64 | 0.300 |
Why?
|
| Prenatal Diagnosis | 1 | 2008 | 73 | 0.300 |
Why?
|
| Cerebellum | 1 | 2008 | 103 | 0.290 |
Why?
|
| Meningioma | 1 | 2007 | 54 | 0.290 |
Why?
|
| Sensitivity and Specificity | 5 | 2021 | 1753 | 0.280 |
Why?
|
| Axons | 2 | 2018 | 139 | 0.280 |
Why?
|
| Protons | 1 | 2007 | 57 | 0.280 |
Why?
|
| Infant, Newborn | 6 | 2021 | 2455 | 0.280 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2007 | 75 | 0.270 |
Why?
|
| Aphasia | 2 | 2018 | 119 | 0.270 |
Why?
|
| Pituitary Diseases | 1 | 2005 | 4 | 0.260 |
Why?
|
| Sella Turcica | 1 | 2005 | 10 | 0.260 |
Why?
|
| Pituitary Gland | 1 | 2005 | 29 | 0.260 |
Why?
|
| Nervous System Malformations | 1 | 2005 | 7 | 0.260 |
Why?
|
| Anxiety | 1 | 2009 | 422 | 0.260 |
Why?
|
| Avitaminosis | 1 | 2005 | 3 | 0.260 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2007 | 346 | 0.260 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 1 | 2005 | 11 | 0.260 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 1 | 2005 | 27 | 0.260 |
Why?
|
| Software | 1 | 2008 | 418 | 0.250 |
Why?
|
| Image Processing, Computer-Assisted | 8 | 2018 | 689 | 0.250 |
Why?
|
| Disease Progression | 4 | 2016 | 1038 | 0.250 |
Why?
|
| Young Adult | 7 | 2021 | 5717 | 0.240 |
Why?
|
| Head and Neck Neoplasms | 1 | 2009 | 561 | 0.230 |
Why?
|
| Cerebrovascular Circulation | 3 | 2013 | 296 | 0.230 |
Why?
|
| Prospective Studies | 5 | 2019 | 3705 | 0.230 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2015 | 134 | 0.220 |
Why?
|
| Radiometry | 2 | 2015 | 64 | 0.210 |
Why?
|
| Follow-Up Studies | 4 | 2017 | 3259 | 0.210 |
Why?
|
| Skull Fractures | 1 | 2021 | 17 | 0.200 |
Why?
|
| Astrocytoma | 2 | 2013 | 30 | 0.190 |
Why?
|
| Heterocyclic Compounds | 1 | 2021 | 24 | 0.190 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2021 | 87 | 0.190 |
Why?
|
| JC Virus | 1 | 2020 | 5 | 0.180 |
Why?
|
| Lymphoma, Follicular | 1 | 2020 | 6 | 0.180 |
Why?
|
| Cognitive Reserve | 1 | 2020 | 6 | 0.180 |
Why?
|
| Leukoaraiosis | 1 | 2020 | 14 | 0.180 |
Why?
|
| Mastoid | 1 | 2020 | 20 | 0.180 |
Why?
|
| Functional Laterality | 3 | 2017 | 240 | 0.180 |
Why?
|
| Equipment Safety | 1 | 2020 | 50 | 0.180 |
Why?
|
| Fatal Outcome | 1 | 2020 | 164 | 0.180 |
Why?
|
| Shock, Septic | 1 | 2020 | 101 | 0.170 |
Why?
|
| Nasal Mucosa | 1 | 2020 | 68 | 0.170 |
Why?
|
| Clostridium Infections | 1 | 2020 | 52 | 0.170 |
Why?
|
| Risk | 3 | 2015 | 563 | 0.170 |
Why?
|
| Temporal Lobe | 2 | 2017 | 125 | 0.170 |
Why?
|
| Bevacizumab | 1 | 2019 | 34 | 0.170 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 151 | 0.170 |
Why?
|
| Mouth Neoplasms | 1 | 2021 | 206 | 0.170 |
Why?
|
| Predictive Value of Tests | 4 | 2017 | 1465 | 0.170 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2021 | 105 | 0.170 |
Why?
|
| Prostheses and Implants | 1 | 2020 | 159 | 0.160 |
Why?
|
| Quality Control | 1 | 2018 | 81 | 0.160 |
Why?
|
| Paranasal Sinuses | 1 | 2020 | 165 | 0.160 |
Why?
|
| Patient Safety | 1 | 2020 | 202 | 0.150 |
Why?
|
| Cerebral Ventricles | 1 | 2017 | 36 | 0.150 |
Why?
|
| Astronauts | 1 | 2017 | 20 | 0.150 |
Why?
|
| Language | 1 | 2018 | 120 | 0.150 |
Why?
|
| Occipital Lobe | 1 | 2017 | 18 | 0.150 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2015 | 125 | 0.150 |
Why?
|
| Weightlessness | 1 | 2017 | 25 | 0.150 |
Why?
|
| Reproducibility of Results | 4 | 2015 | 2077 | 0.140 |
Why?
|
| Pacemaker, Artificial | 1 | 2017 | 157 | 0.140 |
Why?
|
| Glioblastoma | 1 | 2019 | 219 | 0.140 |
Why?
|
| Causality | 1 | 2016 | 82 | 0.140 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 629 | 0.140 |
Why?
|
| Upper Extremity | 1 | 2017 | 112 | 0.130 |
Why?
|
| Models, Anatomic | 1 | 2016 | 51 | 0.130 |
Why?
|
| Sex Distribution | 1 | 2016 | 274 | 0.130 |
Why?
|
| Limbic System | 2 | 2016 | 106 | 0.130 |
Why?
|
| Risk Factors | 3 | 2016 | 5731 | 0.130 |
Why?
|
| Regression Analysis | 1 | 2017 | 737 | 0.130 |
Why?
|
| Feasibility Studies | 2 | 2008 | 652 | 0.130 |
Why?
|
| Axis, Cervical Vertebra | 1 | 2015 | 5 | 0.130 |
Why?
|
| Disability Evaluation | 1 | 2017 | 298 | 0.130 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2015 | 79 | 0.120 |
Why?
|
| Epilepsy, Generalized | 1 | 2014 | 15 | 0.120 |
Why?
|
| Time Factors | 3 | 2020 | 4655 | 0.120 |
Why?
|
| Models, Neurological | 1 | 2015 | 136 | 0.120 |
Why?
|
| Nerve Net | 3 | 2016 | 181 | 0.120 |
Why?
|
| Sex Factors | 2 | 2015 | 1266 | 0.120 |
Why?
|
| Connectome | 1 | 2015 | 92 | 0.110 |
Why?
|
| Cross-Over Studies | 2 | 2015 | 260 | 0.110 |
Why?
|
| Treatment Outcome | 4 | 2021 | 7029 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 627 | 0.110 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2013 | 10 | 0.110 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 49 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1054 | 0.110 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2012 | 4 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 786 | 0.110 |
Why?
|
| Infarction | 1 | 2012 | 17 | 0.100 |
Why?
|
| Incidence | 1 | 2016 | 1603 | 0.100 |
Why?
|
| Comorbidity | 1 | 2016 | 1426 | 0.100 |
Why?
|
| Spinal Cord Diseases | 1 | 2012 | 23 | 0.100 |
Why?
|
| Hematoma, Subdural | 1 | 2011 | 19 | 0.100 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2012 | 61 | 0.100 |
Why?
|
| Salmonella Infections | 1 | 2011 | 11 | 0.100 |
Why?
|
| Salmonella typhimurium | 1 | 2011 | 15 | 0.100 |
Why?
|
| Biomarkers | 2 | 2022 | 1593 | 0.100 |
Why?
|
| Catheters, Indwelling | 1 | 2011 | 72 | 0.100 |
Why?
|
| Research Design | 1 | 2015 | 729 | 0.090 |
Why?
|
| Osteomyelitis | 1 | 2011 | 40 | 0.090 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 334 | 0.090 |
Why?
|
| Pregnancy | 2 | 2008 | 2334 | 0.090 |
Why?
|
| Hearing Loss | 1 | 2013 | 154 | 0.090 |
Why?
|
| Dura Mater | 1 | 2010 | 23 | 0.090 |
Why?
|
| Age Factors | 1 | 2015 | 1864 | 0.090 |
Why?
|
| Capillary Permeability | 1 | 2009 | 69 | 0.090 |
Why?
|
| Alleles | 1 | 2010 | 386 | 0.090 |
Why?
|
| Regional Blood Flow | 1 | 2009 | 168 | 0.090 |
Why?
|
| Thinking | 1 | 2009 | 30 | 0.080 |
Why?
|
| Temperament | 1 | 2009 | 6 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 2279 | 0.080 |
Why?
|
| Observer Variation | 1 | 2010 | 330 | 0.080 |
Why?
|
| Problem Solving | 1 | 2008 | 36 | 0.080 |
Why?
|
| Organ Size | 1 | 2009 | 242 | 0.080 |
Why?
|
| South Carolina | 1 | 2015 | 2752 | 0.080 |
Why?
|
| Frontal Lobe | 1 | 2009 | 156 | 0.080 |
Why?
|
| Syndrome | 1 | 2008 | 255 | 0.080 |
Why?
|
| Rare Diseases | 1 | 2007 | 41 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2010 | 342 | 0.070 |
Why?
|
| Anemia, Sickle Cell | 1 | 2011 | 364 | 0.070 |
Why?
|
| Blood Volume Determination | 1 | 2007 | 3 | 0.070 |
Why?
|
| Neurons | 1 | 2012 | 881 | 0.070 |
Why?
|
| Gray Matter | 2 | 2018 | 57 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 306 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2022 | 2358 | 0.070 |
Why?
|
| Methanol | 1 | 2005 | 9 | 0.060 |
Why?
|
| Mental Processes | 1 | 2005 | 22 | 0.060 |
Why?
|
| Cognition | 1 | 2008 | 513 | 0.060 |
Why?
|
| Social Behavior | 1 | 2005 | 164 | 0.060 |
Why?
|
| United States | 1 | 2016 | 7367 | 0.060 |
Why?
|
| Cerebral Angiography | 2 | 2014 | 151 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 104 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 1 | 2021 | 80 | 0.050 |
Why?
|
| Gadolinium | 1 | 2021 | 88 | 0.050 |
Why?
|
| Hyperemia | 1 | 2020 | 14 | 0.050 |
Why?
|
| Neoplasm Grading | 1 | 2020 | 111 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2013 | 536 | 0.040 |
Why?
|
| Eustachian Tube | 1 | 2020 | 31 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2021 | 714 | 0.040 |
Why?
|
| Pressure | 1 | 2020 | 252 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 800 | 0.040 |
Why?
|
| Ethanol | 1 | 2005 | 893 | 0.040 |
Why?
|
| Machine Learning | 1 | 2020 | 170 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2019 | 163 | 0.040 |
Why?
|
| Cell Count | 1 | 2018 | 248 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 517 | 0.040 |
Why?
|
| Necrosis | 1 | 2018 | 239 | 0.040 |
Why?
|
| Cerebrum | 1 | 2017 | 20 | 0.040 |
Why?
|
| Speech Therapy | 1 | 2017 | 19 | 0.040 |
Why?
|
| Intracranial Pressure | 1 | 2017 | 58 | 0.040 |
Why?
|
| Prognosis | 2 | 2015 | 2093 | 0.040 |
Why?
|
| Radiologists | 1 | 2017 | 35 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 756 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2017 | 94 | 0.040 |
Why?
|
| Decision Making | 1 | 2020 | 410 | 0.030 |
Why?
|
| Gyrus Cinguli | 2 | 2008 | 113 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2016 | 32 | 0.030 |
Why?
|
| Mutation | 1 | 2020 | 1213 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2015 | 236 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2017 | 274 | 0.030 |
Why?
|
| Age of Onset | 1 | 2014 | 188 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2018 | 1330 | 0.030 |
Why?
|
| Carotid Stenosis | 1 | 2014 | 163 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 349 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2014 | 328 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2013 | 143 | 0.030 |
Why?
|
| Infarction, Anterior Cerebral Artery | 1 | 2012 | 4 | 0.030 |
Why?
|
| Muscle Weakness | 1 | 2012 | 26 | 0.030 |
Why?
|
| Prefrontal Cortex | 2 | 2008 | 640 | 0.020 |
Why?
|
| Macrophages | 1 | 2014 | 647 | 0.020 |
Why?
|
| Calcium | 1 | 2014 | 929 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2011 | 453 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2011 | 284 | 0.020 |
Why?
|
| Hippocampus | 1 | 2012 | 471 | 0.020 |
Why?
|
| Reaction Time | 1 | 2009 | 170 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 2007 | 0.020 |
Why?
|
| Mathematics | 1 | 2008 | 83 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 1553 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 1342 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 2008 | 59 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 392 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 1851 | 0.020 |
Why?
|
| Aging | 1 | 2013 | 911 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 540 | 0.020 |
Why?
|
| Recurrence | 1 | 2009 | 948 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2005 | 213 | 0.010 |
Why?
|